United Therapeutics
UTHR
#1117
Rank
C$29.67 B
Marketcap
C$691.84
Share price
-0.53%
Change (1 day)
20.23%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): C$40.40

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$41.01. In 2025 the company made an earnings per share (EPS) of C$42.21 an increase over its 2024 EPS that were of C$37.00.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$40.40-4.29%
2025C$42.2114.1%
2024C$37.0025.59%
2023C$29.4631.54%
2022C$22.3951.18%
2021C$14.81-9.1%
2020C$16.29-581.4%
2019C-$3.38-117.79%
2018C$19.0242.11%
2017C$13.39-40.93%
2016C$22.6613.45%
2015C$19.97104.29%
2014C$9.78100.29%
2013C$4.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.83-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.48-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.98-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.38-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$9.19-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.44-86.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
C-$9.57-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.92-95.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel